Last updated: February 6, 2018
Sponsor: Epicentre
Overall Status: Completed
Phase
4
Condition
Meningitis
Treatment
N/AClinical Study ID
NCT02724046
Ciprofloxacin chemoprophylaxis
All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Resident in a village included in the study area
Exclusion
Exclusion Criteria:
Patients currently exhibiting symptoms of meningitis (to be immediately referred forfurther care)
Persons with a known allergy to fluoroquinolone antibiotics.
Study Design
Total Participants: 300
Study Start date:
April 22, 2017
Estimated Completion Date:
June 12, 2017
Study Description
Connect with a study center
Madarounfa Health District
Madarounfa, Maradi
NigerSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.